Philips Respironics V60 Ventilator Flow Rate Reduction Safety Defect
Philips Respironics V60 ventilators with High Flow Therapy software versions 3.00 and 3.10 may reduce oxygen delivery below prescribed levels when pressure limits are reached, risking oxygen desaturation.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class I recall, which mandates a minimum severity score of 4 per the classification rules. The defect creates a risk of oxygen desaturation and hypoxemia in ventilator-dependent patients, though no injuries or deaths are reported in the source material.
Plain-English summary
Philips Respironics V60 ventilators equipped with High Flow Therapy (software versions 3.00 and 3.10) are subject to this FDA Class I recall. The devices are intended to augment breathing in spontaneously breathing individuals requiring mechanical ventilation in hospital and institutional settings.
The ventilators contain a designed safety mechanism that limits maximum pressure delivery to patients. When system pressure reaches this limit and triggers a "Cannot Reach Target Flow" alarm, the ventilator reduces both pressure and flow rate below the level set by clinicians. If the underlying pressure issue persists, the ventilator continues delivering the lower flow rate rather than alerting clinicians to the problem.
This defect can result in patients experiencing oxygen desaturation, characterized as moderate or severe hypoxemia, potentially putting ventilator-dependent patients at risk.
Approximately 23,115 V60/V60 Plus systems have been distributed worldwide. Clinicians and healthcare facilities using these devices should review the recall details and consult manufacturer guidance for corrective action or firmware updates.
The recalled product
- Product
- Philips Respironics V60 Ventilator with Software Versions 3.00 and 3.10. The Respironics V60/V60 Plus Ventilator is an assist ventilator and is intended to augment patient breathing. It is intended for spontaneously breathing individuals who require mechanical ventilation: pat
- Manufacturer
- Respironics California, LLC
- Category
- Medical Device — Ventilator
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Model V60 Ventilator: P/N 1053613
- 1053614
- 1053615
- 1053616
- 1053617
- DU1053617
- U1053617
- 1076716
Distribution
Part of a larger recall action
This product is one of 2 recalled by Respironics California, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Respironics California, LLC
See all →- SeverePhilips Respironics V680 Ventilator May Stop Operating Due to Electrical Fault
FDA (Devices) · 2022-04-27
- SeverePhilips Respironics V60 Plus Ventilator Recalled for Electrical Circuit Failure Risk
FDA (Devices) · 2022-04-27
- SeverePhilips Respironics V60 Ventilator Recalled Due to Electrical Circuit Defect
FDA (Devices) · 2022-04-27
- SeverePhilips Respironics V60 Plus Ventilators with Defective Adhesive Recalled
FDA (Devices) · 2022-03-09
- SeverePhilips V60 Ventilator Recall: Expired Adhesive May Cause Device Failure
FDA (Devices) · 2022-03-09
Same hazard · hypoxemia
See all →- SeverePhilips OmniLab Advanced + Ventilator May Experience Unexpected Therapy Loss
FDA (Devices) · 2024-05-29
- SevereBiPAP A30 Ventilator Recall: Risk of Therapy Interruption and Respiratory Failure
FDA (Devices) · 2024-05-29
- SevereBiPAP V30 Auto Ventilator May Interrupt Therapy During Malfunction Alarm
FDA (Devices) · 2024-05-29
- SevereBiPAP A40 ventilators risk therapy loss during alarm condition
FDA (Devices) · 2024-05-29
- SevereTrilogy Evo O2 EV300 respiratory devices recalled for debris accumulation
FDA (Devices) · 2023-06-14